Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer

被引：27

作者：

Wei, Yuanyuan ^{[1
,2
]}

Zhu, Mengyu ^{[1
]}

Schober, Andreas ^{[1
,2
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Expt Vasc Med, D-80336 Munich, Germany

[2] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, D-80802 Munich, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2018年 / 19卷 / 06期

关键词：

immune disorders; microRNA; macrophage; lipid metabolism; chronic inflammation; TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; ADIPOSE-TISSUE MACROPHAGES; COLONY-STIMULATING FACTOR; NITRIC-OXIDE SYNTHASE; PROMOTES ATHEROSCLEROSIS; ALTERNATIVE ACTIVATION; CHOLESTEROL EFFLUX; KETONE-BODIES; IMMUNE CELLS;

D O I：

10.3390/ijms19061756

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Macrophages play a crucial role in the innate immune system and contribute to a broad spectrum of pathologies in chronic inflammatory diseases. MicroRNAs (miRNAs) have been demonstrated to play important roles in macrophage functions by regulating macrophage polarization, lipid metabolism and so on. Thus, miRNAs represent promising diagnostic and therapeutic targets in immune disorders. In this review, we will summarize the role of miRNAs in atherosclerosis, metabolic syndrome, and cancer by modulating macrophage phenotypes, which has been supported by in vivo evidence.

引用

页数：20

共 50 条

[41] MicroRNAs and Ultraconserved Genes as Diagnostic Markers and Therapeutic Targets in Cancer and Cardiovascular Diseases [J].

Edwards, Julianna K. ;

Pasqualini, Renata ;

Arap, Wadih ;

Calin, George A. .

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (03) :271-279

[42] MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets [J].

Huang, J. ;

Zhang, S. -Y. ;

Gao, Y. -M. ;

Liu, Y. -F. ;

Liu, Y. -B. ;

Zhao, Z. -G. ;

Yang, K. .

CELL PROLIFERATION, 2014, 47 (04) :277-286

[43] MicroRNAs in blood act as biomarkers of colorectal cancer and indicate potential therapeutic targets [J].

Stang, Axel ;

Weilert, Hauke ;

Lipp, Michael J. ;

Oldhafer, Karl J. ;

Hoheisel, Joerg D. ;

Zhang, Chaoyang ;

Bauer, Andrea S. .

MOLECULAR ONCOLOGY, 2021, 15 (09) :2480-2490

[44] MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer [J].

Doldi, Valentina ;

El Bezawy, Rihan ;

Zaffaroni, Nadia .

CANCERS, 2021, 13 (10)

[45] MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis [J].

Hur, Keun .

BMB REPORTS, 2015, 48 (04) :217-222

[46] Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome? [J].

Rocic, Petra .

CURRENT DRUG TARGETS, 2017, 18 (15) :1722-1732

[47] microRNAs as pharmacological targets in cancer [J].

Soriano, Aroa ;

Jubierre, Luz ;

Almazan-Moga, Ana ;

Molist, Carla ;

Roma, Josep ;

Sanchez de Toledo, Jose ;

Gallego, Soledad ;

Segura, Miguel F. .

PHARMACOLOGICAL RESEARCH, 2013, 75 :3-14

[48] Roles of microRNAs and their targets in cancer [J].

Stefani, Giovanni .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) :1833-1840

[49] Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets [J].

Dominiak, Agnieszka ;

Chelstowska, Beata ;

Nowicka, Grazyna .

CANCERS, 2025, 17 (14)

[50] MicroRNAs: role and therapeutic targets in viral hepatitis [J].

van der Ree, Meike H. ;

de Bruijne, Joep ;

Kootstra, Neeltje A. ;

Jansen, Peter L. M. ;

Reesink, Hendrik W. .

ANTIVIRAL THERAPY, 2014, 19 (06) :533-541

← 1 2 3 4 5 →